Mirum Pharma: A Rare Disease Growth Story to Watch
20/5 18:35
Mirum Pharmaceuticals (NASDAQ: MIRM) is a late-stage biotechnology company that is making significant progress toward its mission to combat rare diseases with no or limited treatment options. Mirum recently reported its Q1 2026 earnings, headlined by 43% year-over-year (YOY) rev...